Location History:
- New York, CT (US) (2005)
- New York, NY (US) (2009 - 2014)
- Monza, IT (2014)
- Ingelheim am Rhein, DE (2014)
- Newtown, CT (US) (2011 - 2015)
- Biberach an der Riss, DE (2012 - 2023)
Company Filing History:
39 out of 1,535 
6 out of 36 
4 out of 276 
Years Active: 2005-2025
Title: Doris Riether: Innovator in Pharmaceutical Chemistry
Introduction
Doris Riether, based in Biberach an der Riss, Germany, is a prominent inventor known for her significant contributions to pharmaceutical chemistry. With an impressive portfolio of 48 patents, Riether is dedicated to the development of innovative compounds aimed at improving therapeutic outcomes, particularly in relation to cannabinoid receptors and orexin receptor interactions.
Latest Patents
Among her latest inventions are two noteworthy patents. The first, titled "(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles," focuses on novel compounds that act as CB2 cannabinoid receptor agonists. This invention also encompasses pharmaceutical compositions containing these compounds for the treatment of CB2 receptor-mediated disorders. The second recent patent, "N-(2,2-difluoroethyl)-N-[(pyrimidinylamino)propanyl]arylcarboxamides," details derivatives designed for therapeutic use, particularly in the treatment or prevention of conditions associated with the orexin sub-type 1 receptor.
Career Highlights
Doris Riether has had an illustrious career, primarily working with notable companies in the pharmaceutical sector. She has contributed her expertise to Boehringer Ingelheim International GmbH and Centrexion Therapeutics Corporation, where she played a crucial role in advancing drug development initiatives. Her work has had a profound impact on the realm of pharmaceutical innovations, positioning her as a key figure in her field.
Collaborations
Throughout her career, Riether has collaborated with esteemed professionals, including Renee M. Zindell and Eugene R. Hickey. These partnerships have enriched her research endeavors and contributed to the successful realization of her innovative ideas.
Conclusion
Doris Riether's contributions to the field of pharmaceutical chemistry illustrate her inventive spirit and dedication to enhancing therapeutic interventions. Her notable patents and collaborative efforts have not only established her as a leading inventor but also paved the way for future innovations in the treatment of complex disorders.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.